The Post-translational Modifications of Smurf2 in TGF-β Signaling

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2020 Aug 1

PMID 32733916

Citations 19

Authors

Yangjinming Bai

Ying Ying

Affiliations

Soon will be listed here.

Abstract

Smad ubiquitin regulatory factor 2 (Smurf2), an essential negative regulator of TGF-β signaling, ubiquitinates TGF-β receptors (TβRs) and Smad proteins, inducing their proteasomal degradation. Smurf2 plays crucial roles in regulating TGF-β signaling and maintaining normal cellular functions and tissue homeostasis; dysfunction of Smurf2 triggers abnormal TGF-β signaling in pathological states. Smurf2 has been reported as a potentially strong candidate for targeting therapies for related diseases. Recent work has begun to focus on the regulation of Smurf2 itself, and emerging evidence indicates that Smurf2 is regulated by post-translational modifications (PTMs) mechanisms. These mechanisms predominantly regulate the expression level and E3 ligase activity of Smurf2, strongly suggesting that this protein contributes to complicated roles under multiple pathophysiological conditions. In this review, we cover some significant and novel mechanisms of the PTMs that potentially control Smurf2 participation in TGF-β signaling, including ubiquitylation, SUMOylation, neddylation, phosphorylation, and methylation in order to provide a broad view of the depth and sophistication of Smurf2 function in TGF-β regulation, as well as perspectives for future therapeutic directions for its associated diseases.

Citing Articles

NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets.

Wu H, Zuo J, Dai Y, Li H, Wang S J Orthop Surg Res. 2025; 20(1):92.

PMID: 39849530 PMC: 11761774. DOI: 10.1186/s13018-025-05517-5.

Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy.

Youssef E, Zhao S, Purcell C, Olson G, El-Deiry W Front Oncol. 2024; 14:1484515.

PMID: 39697237 PMC: 11652374. DOI: 10.3389/fonc.2024.1484515.

A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling.

Li X, Kempf S, Delgado Lagos F, Ukan U, Popp R, Hu J iScience. 2024; 27(10):110938.

PMID: 39398242 PMC: 11466655. DOI: 10.1016/j.isci.2024.110938.

SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis.

Zhang Y, Yang Y, Qi X, Cui P, Kang Y, Liu H J Exp Clin Cancer Res. 2024; 43(1):208.

PMID: 39061061 PMC: 11282742. DOI: 10.1186/s13046-024-03114-8.

Role of ubiquitination in the occurrence and development of osteoporosis (Review).

Fan X, Zhang R, Xu G, Fan P, Luo W, Cai C Int J Mol Med. 2024; 54(2).

PMID: 38940355 PMC: 11232666. DOI: 10.3892/ijmm.2024.5392.

References

Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K . NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Biochem J. 2004; 386(Pt 3):461-70. PMC: 1134864. DOI: 10.1042/BJ20040738. View

Kamitani T, Kito K, Nguyen H, Yeh E . Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997; 272(45):28557-62. DOI: 10.1074/jbc.272.45.28557. View

Enchev R, Schulman B, Peter M . Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 2014; 16(1):30-44. PMC: 5131867. DOI: 10.1038/nrm3919. View

Xie P, Zhang M, He S, Lu K, Chen Y, Xing G . The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nat Commun. 2014; 5:3733. DOI: 10.1038/ncomms4733. View

Manikoth Ayyathan D, Koganti P, Marcu-Malina V, Litmanovitch T, Trakhtenbrot L, Emanuelli A . SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis. Oncogene. 2020; 39(16):3396-3410. DOI: 10.1038/s41388-020-1226-3. View

Bonni S, Wang H, Causing C, Kavsak P, Stroschein S, Luo K . TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol. 2001; 3(6):587-95. DOI: 10.1038/35078562. View

David D, Nair S, Pillai M . Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression. Biochim Biophys Acta. 2012; 1835(1):119-28. DOI: 10.1016/j.bbcan.2012.11.003. View

Ogunjimi A, Briant D, Pece-Barbara N, Le Roy C, Di Guglielmo G, Kavsak P . Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell. 2005; 19(3):297-308. DOI: 10.1016/j.molcel.2005.06.028. View

Iezaki T, Fukasawa K, Horie T, Park G, Robinson S, Nakaya M . The MAPK Erk5 is necessary for proper skeletogenesis involving a Smurf-Smad-Sox9 molecular axis. Development. 2018; 145(14). DOI: 10.1242/dev.164004. View

10.

Ohashi N, Yamamoto T, Uchida C, Togawa A, Fukasawa H, Fujigaki Y . Transcriptional induction of Smurf2 ubiquitin ligase by TGF-beta. FEBS Lett. 2005; 579(12):2557-63. DOI: 10.1016/j.febslet.2005.03.069. View

11.

Ramkumar C, Kong Y, Cui H, Hao S, Jones S, Gerstein R . Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. Cancer Res. 2012; 72(11):2714-9. PMC: 3616636. DOI: 10.1158/0008-5472.CAN-11-3773. View

12.

Chanda A, Sarkar A, Bonni S . The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression. Cancers (Basel). 2018; 10(8). PMC: 6115711. DOI: 10.3390/cancers10080264. View

13.

Cui Y, He S, Xing C, Lu K, Wang J, Xing G . SCFFBXL¹⁵ regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1. EMBO J. 2011; 30(13):2675-89. PMC: 3155294. DOI: 10.1038/emboj.2011.155. View

14.

Kavsak P, Rasmussen R, Causing C, Bonni S, Zhu H, Thomsen G . Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell. 2001; 6(6):1365-75. DOI: 10.1016/s1097-2765(00)00134-9. View

15.

Wegner K, Bachmann A, Schad J, Lucarelli P, Sahle S, Nickel P . Dynamics and feedback loops in the transforming growth factor β signaling pathway. Biophys Chem. 2012; 162:22-34. DOI: 10.1016/j.bpc.2011.12.003. View

16.

Subramaniam V, Li H, Wong M, Kitching R, Attisano L, Wrana J . The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer. 2003; 89(8):1538-44. PMC: 2394340. DOI: 10.1038/sj.bjc.6601301. View

17.

Emanuelli A, Manikoth Ayyathan D, Koganti P, Shah P, Apel-Sarid L, Paolini B . Altered Expression and Localization of Tumor Suppressive E3 Ubiquitin Ligase SMURF2 in Human Prostate and Breast Cancer. Cancers (Basel). 2019; 11(4). PMC: 6521037. DOI: 10.3390/cancers11040556. View

18.

Hua F, Mu R, Liu J, Xue J, Wang Z, Lin H . TRB3 interacts with SMAD3 promoting tumor cell migration and invasion. J Cell Sci. 2011; 124(Pt 19):3235-46. DOI: 10.1242/jcs.082875. View

19.

Fukuchi M, Fukai Y, Masuda N, Miyazaki T, Nakajima M, Sohda M . High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Res. 2002; 62(24):7162-5. View

20.

Li Y, Yang D, Tian N, Zhang P, Zhu Y, Meng J . The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation. J Biol Chem. 2019; 294(40):14745-14756. PMC: 6779433. DOI: 10.1074/jbc.RA119.007508. View